Robert Spurr is President at Bausch Health Companies Inc. (BHC). They have made 3 open-market trades across 1 company since 2022, most recently 2022-05-10.
CIK 0001543795
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| BHC | 112,741 | $941K |
Shares reported on the most recent Form 4, priced at the 2022-05-12 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BHC | SELL · 10b5-1 | 2022-04-14 | 2022-04-15 | $22.19 | $35K | -6.8% | -51.2% | -60.4% |
| BHC | SELL | 2022-03-15 | 2022-03-16 | $22.20 | $215K | -1.9% | -8.6% | -67.8% |
| BHC | SELL · 10b5-1 | 2022-03-02 | 2022-03-04 | $23.37 | $37K | +0.8% | +3.3% | -57.9% |
| BHC | SELL | 2022-02-15 | 2022-02-17 | $25.02 | $163K | -1.9% | -4.1% | -59.6% |
| BHC | SELL | 2022-01-18 | 2022-01-20 | $26.63 | $173K | +1.3% | -4.6% | -7.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.